Intellectus Partners, LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 37 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2018. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Intellectus Partners, LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q3 2018$1,000
-50.0%
1000.0%0.00%
-100.0%
Q2 2018$2,000
-33.3%
1000.0%0.00%0.0%
Q1 2018$3,000–100–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q2 2018.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders